Effect of Immune Enhancement Intervention on Clinical Outcomes of Patients with Breast Cancer Undergoing Chemotherapy | ||
| Egyptian Journal of Health Care | ||
| Article 114, Volume 12, Issue 3, September 2021, Pages 1840-1857 PDF (609.91 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhc.2021.235593 | ||
| Authors | ||
| Jackleen Faheem Gendy; Fatma Mostafa Mahrous | ||
| Medical-Surgical Nursing Department– Faculty of Nursing- Ain Shams University. | ||
| Abstract | ||
| Breast cancer (BC) is the most frequently diagnosed malignancy and ranks as the leading cause of cancer-related deaths among females worldwide. After lung cancer, it is the second-largest cause of death. Systemic chemotherapy is used to treat more than half of the individuals with BC. They are effective at destroying cancer cells, but they can temporarily display immune dysfunction. The immune system is critical to rebuild and maintain the immune system in optimal fighting shape. The present study aimed to evaluate the effect of immune enhancement intervention on clinical outcomes of patients with BC undergoing chemotherapy. The research design was quasi experimental. Setting: It was conducted at the oncology center and nuclear medicine at Ain Shams University Hospitals. Sample: A purposive sample of 100 patients was sorted into two groups: control and study. Tools of data collection: Data were collected using a structured interviewing questionnaire, a Scale for assessing one's quality of life, an Australia-modified Karnofsky performance status scale & a nutritional assessment sheet that includes a lab investigation & tumor marker. The results: The study group (60%) and the control group (68%) were married and between the ages of 50 and 70 years old, respectively, and there was a highly significant difference between the two groups in terms of knowledge, quality of life, performance status for usual activities, and nutritional status post-intervention, which led to a highly significant decrease in tumor biomarkers among the study group versus the control group. Conclusion: Patients with BC who were undergoing chemotherapy saw a statistically significant improvement in their clinical outcomes after participating in an immune enhancement intervention program. Recommendations: More researches are needed to conduct training and instruction, to study the impact of the immune enhancement intervention program on the clinically outcomes and quality of life of the patients. | ||
| Keywords | ||
| Breast Cancer; Chemotherapy; Immune System Enhancement | ||
|
Statistics Article View: 148 PDF Download: 120 |
||
